News briefing: Gilead submits filgotinib to European regulators for UC; GW Pharmaceuticals launches PhIII trial for MS candidate made with cannabis extracts Endpoints News
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform The Lancet
Bristol Myers Squibb Data at ACR Convergence 2020 Underscore Commitment to Advancing Science for Patients with Difficult-to-Treat Immune-Mediated Diseases Business Wire
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform The Lancet
The global autoimmune disease diagnostics market is projected to generate a revenue of $10012.9 million by 2030, and is predicted to progress at an 8.5% CAGR during the time period 2020-2030 Stockhouse
Association between thiazolidinedione use and rheumatoid arthritis risk in patients with type II diabetes, a population-based, case-control study DocWire News
Innovations in the Rheumatoid Arthritis Stem Cell Therapy Field Likely to Aid the Growth of the Rheumatoid Arthritis Stem Cell Therapy Market 2018 to 2028 Zenit News